E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/20/2022 in the Prospect News Distressed Debt Daily.

Certa Dose reports $56,895 net loss for April

By Sarah Lizee

Olympia, Wash., May 20 – Certa Dose, Inc. reported a $56,895 net loss on $41,199 of gross income/sales for April, according to its monthly operating reported filed Friday with the U.S. Bankruptcy Court for the Southern District of New York.

The company listed $85,530 in cash at the end of the month.

The New York-based company develops, licenses and sells pharmaceutical products and technology. The company filed bankruptcy on May 30, 2021 under Chapter 11 case number 21-11045.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.